Liquid Embolic Market Size, Share & Trends Analysis | Global | 2023-2029 | MedCore

The global market for liquid embolics was estimated to be worth around $130 million in 2022 and is anticipated to grow at a compound annual growth rate (CAGR) of 1.4% during the forecast period, reaching a value of $145 million. The complete report suite on the global liquid embolics market covers only liquid embolics.

MARKET REPORT DATA TYPES INCLUDED

Unit Sales, Average Selling Prices, Market Size & Growth Trends

Procedure Numbers

COVID-19 Impact Analysis

Market Drivers & Limiters

Market Forecasts Until 2029, and Historical Data to 2019

Recent Mergers & Acquisitions

Company Profiles and Product Portfolios

Leading Competitors

GLOBAL LIQUID EMBOLIC MARKET INSIGHTS

One of the main factors driving the global liquid embolic market is the less invasive nature of the treatment, which does not require open surgery, resulting in reduced patient recovery time. In contrast, coiling procedures still face challenges that could restrict market expansion, such as complications including catheter entrapment leading to serious issues such as hemorrhage, death, or migration of catheter fragments to other parts of the body.

GLOBAL LIQUID EMBOLIC MARKET SHARE INSIGHTS

Within the global market for liquid embolics, there are three key market players - Medtronic, Cerenovus, and MicroVention.

Stryker held the top position in the global detachable coil market in 2022, with a particular emphasis on the bare platinum segment. The GDC® 360° detachable coil, a treatment for neurovascular aneurysm occlusion, is widely considered the gold standard and has played a pioneering role in advancing endovascular treatment for intracranial aneurysms.

MARKET SEGMENTATION SUMMARY

Global Liquid Embolic Market

RESEARCH SCOPE SUMMARY

Regions: North America (Canada, United States), Latin America (Argentina, Brazil, Chile, Colombia, Mexico, Peru, Venezuela), Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, U.K.), Central & Eastern Europe (Baltic States, Bulgaria, Croatia, Czech Republic, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Turkey, Ukraine), Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates), Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Philippines, Singapore, South Korea, Taiwan, Thailand, Vietnam), Africa (Algeria, Egypt, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda)

Base Year: 2022

Forecast: 2023-2029

Historical Data: 2019-2022

Quantitative Coverage: Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices.

Qualitative Coverage: COVID19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews.

Data Sources: Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database.

WHY CHOOSE IDATA?

Experts Only - iData has been around for over 17 years and is the trusted source of intelligence, and data-driven insights for key industry players. We are made up of specialists with a sole focus on medical devices, dental devices and pharmaceuticals. Our research and consulting field of endeavour never strays from the medical device industry and, because of this, we are the number one choice for leading companies in this field.

Global Coverage - iData's unique methodology, and its expansion to over 70 countries world-wide, has made it one of the most viable sources of intelligence for global companies along with those who plan to expand their portfolio beyond the confines of their own country. Providing procedural data at the country level is another testimony to the trusted global coverage we provide.

Attention to Detail - It's our attention to small details, scheduling of timelines, and keen project management that makes us stand out from the rest. We are creative, and our reports include metrics such as procedure numbers, ASPs, and SKU-level insights that are not found elsewhere.

Pricing - When comparing like-with-like, iData's prices are not only extremely competitive but also the most cost-effective. We strive for success and want the same for our clients. With the level of detail incorporated into each report alongside the extensive segmentation provided, no other report compares at our price point.